PTH and bortezomib suppress growth of primary human myeloma through increased bone formation in vivo.

被引：0
|
作者：
Pennisi, Angela [1 ]
Ling, Wen [1 ]
Perkins, Paul [1 ]
Saha, Rinku [1 ]
Li, Xin [1 ]
Barlogie, Bart [1 ]
Tricot, Guido [1 ]
Zangari, Maurizio [1 ]
Yaccoby, Shmuel [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Theraphy, Little Rock, AR 72205 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
509
引用
收藏
页码：154A / 154A
页数：1
相关论文
共 50 条
  • [41] Activation of human platelet-rich plasmas:: effect on growth factors release, cell division and in vivo bone formation
    Roussy, Yanik
    Duchesne, Marie-Pierre Bertrand
    Gagnon, Guy
    CLINICAL ORAL IMPLANTS RESEARCH, 2007, 18 (05) : 639 - 648
  • [42] The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
    K Yata
    S Yaccoby
    Leukemia, 2004, 18 : 1891 - 1897
  • [43] The SCID-rab model:: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
    Yata, K
    Yaccoby, S
    LEUKEMIA, 2004, 18 (11) : 1891 - 1897
  • [44] Receptor activator of nuclear factor-κB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo
    Farrugia, AN
    Atkins, GJ
    To, LB
    Pan, BQ
    Horvath, N
    Kostakis, P
    Findlay, DM
    Bardy, P
    Zannettino, ACW
    CANCER RESEARCH, 2003, 63 (17) : 5438 - 5445
  • [45] Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication
    Candelaria, Pierre V.
    Nava, Miguel
    Martinez-Maza, Otoniel
    Daniels-Wells, Tracy R.
    Penichet, Manuel L.
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (05) : 227 - 230
  • [46] Connective tissue growth factor (CTGF/CCN2) enhanced human bone marrow stromall cell attachment in vitro and migration and survival of the cells in a hydroxyapatite scaffold in vivo.
    Ono, M
    Sonoyama, W
    Akiyama, K
    Fujisawa, T
    Nishida, T
    Takigawa, M
    Kuboki, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S203 - S204
  • [47] Promotion of human multiple myeloma cell growth in vitro and bone marrow invasion in vivo by Notch receptors and the CXCR4/SDF1 axis
    Chiriva-Internati, Maurizio
    Mirandola, Leonardo
    Lazzari, Elisa
    Colombo, Michela
    Lancellotti, Marialuigia
    Cobos, Everardo
    Yu, Yuefei
    Figueroa, Jose A.
    Saadeh, Charles
    Wade, Raymond
    Zepeda, Kristopher
    Mer, Jesse
    Konala, Venu
    Radhi, Saba
    Aulakh, Amardeep
    Jenkins, Marjorie
    Jumper, Cynthia A.
    Alalawi, Raed
    Chiaramonte, Raffaella
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo
    Richman, C
    Baylink, DJ
    Lang, K
    Dony, C
    Mohan, S
    ENDOCRINOLOGY, 1999, 140 (10) : 4699 - 4705
  • [49] Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor
    Broek, IV
    Asosingh, K
    Allegaert, V
    Leleu, X
    Facon, T
    Vanderkerken, K
    Van Camp, B
    Van Riet, I
    LEUKEMIA, 2004, 18 (05) : 976 - 982
  • [50] Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor
    I Vande Broek
    K Asosingh
    V Allegaert
    X Leleu
    T Facon
    K Vanderkerken
    B Van Camp
    I Van Riet
    Leukemia, 2004, 18 : 976 - 982
12345